FINDING NEW INHIBITORS FOR EML4-ALK FUSION PROTEIN: A COMPUTATIONAL APPROACH
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 3
Abstract
The fusion between echinoderm microtubule-associated protein-like 4 (EML4) and anaplastic lymphoma kinase (ALK) has recently been identified in a subset of non-small cell lung cancers (NSCLC). PF-02341066 (crizotinib) is an orally bioavailable ALK inhibitor currently under clinical development. PF-02341066 in EML4-ALK NSCLC was designed for patients not eligible for the phase III trial or patients randomized to chemotherapy who subsequently developed progressive disease. PF-02341066 is a dual inhibitor of mesenchymal epithelial transition growth factor (c-met) and anaplastic lymphoma kinase translocation gene and caused tumour shrinkage in 52% of patients in a phase I study. However, some studies also show denovo mutations within the kinase domain of EML4-ALK that confers resistance to multiple ALK inhibitors. Hence development of new inhibitors with better binding affinities towards the EML4-ALK is the need of the hour for subsequent clinical validation. Computational (virtual) screening of drug-like compounds against the protein targets like EML4-ALK, might help to identify specific lead inhibitors more efficiently. The Protein- Ligand interaction plays a significant role in structure based drug designing. In the current study, we have considered EML4-ALK, a fusion protein involved in NSCLCs as a receptor and NCI subset Ligands as drugs. The receptor was docked to the NCI database of drugs and a docking score was calculated using GLIDE docking software. Based on the docking score, we choose the best drugs and analyzed its ADME properties using Qikprop tool. The results of this analysis show some novel compounds that can be further evaluated as EML4-ALK inhibitors in experimental NSCLC cell lines. The study further supports the application of computer-aided techniques to the discovery of novel and specific drug for EML4-ALK fusion protein.
Authors and Affiliations
Sabitha Kesavan , Vijayalakshmi Ramshankar
Keywords
Related Articles
- EP ID EP145567
- DOI -
- Views 113
- Downloads 0
EFFECT OF ERYTHROMYCINE IN ALTERED GASTRIC MOTILITY AND PH IN WISTAR RATS
Drug absorption through the gastrointestinal tract plays a major role in determining the systemic exposure of the drugs when administered by oral route. The physicochemical properties of the drug like particle size, poly...
MEDICINAL PLANTS OF RAJASTHAN (INDIA) WITH ANTIDIABETIC POTENTIAL
Rajasthan has a rich heritage of traditional system of medicine and many medicinally useful plants are found growing wildly because of vast area and variety of agro-climatic conditions. These plants are being used for th...
EVALUATION OF NOOTROPIC ACTIVITY OF POLYHERBAL FORMULATION SR-105 IN EXPERIMENTAL ANIMALS
The main objective of the proposed work is to evaluate the beneficial effect of SR-105 on CNS mainly for its locomotor and nootropic activities in different experimental animal models like passive paradigm, sodium nitrit...
FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE BILAYER TABLETS OF TELMISERTAN AND HYDROCHLOROTHIAZIDE
A low-dose combination of two different agents reduces the dose related risk; the addition of one agent may counter act some deleterious effects of the other. Using low dosage of two different agents minimizes the clinic...
DEVELOPMENT AND CHARACTERIZATION OF CHITOSAN NANOPARTICLES LOADED WITH AMOXYCILLIN
This work presents result of the development and characterization of nanoparticles for entrapping Amoxicillin, an anti microbial agent. The present study was to focus on the development of amoxicillin loaded chitosan TPP...